Evidence map›Paper›PMID 25875493›Full record

ArticlePloS one2015

Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P).

Priscilla A Williams, Roberta S Stilhano, Vivian P To, Lyndon Tran, Kevin Wong, Eduardo A Silva

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Low-dose ionizing radiationMaterials today. Bio · 2025
    Article
  4. Article
  5. Article
  6. International journal of stem cells · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Human amnion extracellular matrix derived bioactive hydrogel for cell delivery and tissue engineering.Materials science & engineering. C, Materials for biological applications · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Priscilla A WilliamsDepartment of Biomedical Engineering, University of California Davis, Davis, California, United States of America.
Roberta S StilhanoDepartment of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Vivian P ToDepartment of Biomedical Engineering, University of California Davis, Davis, California, United States of America.
Lyndon TranDepartment of Neurobiology, Physiology, and Behavior, University of California Davis, Davis, California, United States of America.
Kevin WongDepartment of Biomedical Engineering, University of California Davis, Davis, California, United States of America.
Eduardo A SilvaDepartment of Biomedical Engineering, University of California Davis, Davis, California, United States of America.
University of California, Davis · USUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic angiogenesis provides a promising approach to treat ischemic cardiovascular diseases through the delivery of proangiogenic cells and/or molecules. Outgrowth endothelial cells (OECs) are vascular progenitor cells that are especially suited for therapeutic strategies given their ease of noninvasive isolation from umbilical cord or adult peripheral blood and their potent ability to enhance tissue neovascularization. These cells are recruited to sites of vascular injury or tissue ischemia and directly incorporate within native vascular endothelium to participate in neovessel formation. A better understanding of how OEC activity may be boosted under hypoxia with external stimulation by proangiogenic molecules remains a challenge to improving their therapeutic potential. While vascular endothelial growth factor (VEGF) is widely established as a critical factor for initiating angiogenesis, sphingosine-1-phosphate (S1P), a bioactive lysophospholipid, has recently gained great enthusiasm as a potential mediator in neovascularization strategies. This study tests the hypothesis that hypoxia and the presence of VEGF impact the angiogenic response of OECs to S1P stimulation in vitro. We found that hypoxia altered the dynamically regulated S1P receptor 1 (S1PR1) expression on OECs in the presence of S1P (1.0 μM) and/or VEGF (1.3 nM). The combined stimuli of S1P and VEGF together promoted OEC angiogenic activity as assessed by proliferation, wound healing, 3D sprouting, and directed migration under both normoxia and hypoxia. Hypoxia substantially augmented the response to S1P alone, resulting in ~6.5-fold and ~25-fold increases in sprouting and directed migration, respectively. Overall, this report highlights the importance of establishing hypoxic conditions in vitro when studying ischemia-related angiogenic strategies employing vascular progenitor cells.

Indexed as

AlginatesBiological AssayCell HypoxiaCell MovementCell ProliferationEndothelium, VascularGene ExpressionGlucuronic AcidHexuronic AcidsHumansHuman Umbilical Vein Endothelial CellsHydrogelsLysophospholipidsNeovascularization, PhysiologicOxygenReceptors, LysosphingolipidAlginatesGlucuronic AcidHexuronic AcidsHydrogelsLysophospholipidsOxygenReceptors, LysosphingolipidS1PR1 protein, humanSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate ReceptorsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID25875493
PMCPMC4398361
OpenAlexW1981123388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.